Clinical Trial Update: Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 18F-rhPSMA-7.3 PET/CT with and without furosemide in biochemical recurrence of prostate cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-rhPSMA-7.3 (rhPSMA-7.3 radiotracer)

Snippet

Sponsor: Emory University | Conditions: Prostate Adenocarcinoma, Recurrent Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-27